… identify novel potential mediators, including LoF of TGFBR2 in NSCLC, CYLD in head and neck cancer, and RUNX1 in triple-negative bre…
non-small cell lung cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning non-small cell lung cancer
126 articles · page 4 of 11…A man in his 60s with metastatic lung adenocarcinoma receiving carboplatin, pemetrexed and pembrolizumab presented w…
…his study examined how PRO data from pivotal clinical trials in breast cancer (BC), gastrointestinal (GI) cancers and non-small cell lung can…
…I; and the American Lung Association and Lung Cancer Europe for NSCLC. Selection of patient-advocacy organisations was guided by thre…
…comparison to VATS, on overall survival in operable early stage NSCLC patients.Methods and analysis Data on NSCLC patients will be co…
…patient enrollment. Patients were included if they had advanced NSCLC, and were first-time users of immune checkpoint inhibitor (ICI)…
…cell-mediated tumor cell killing activity and a syngeneic mouse NSCLC model were used to assess the influence of USP15 and U10 on NSC…
…Background and Importance Non-small cell lung cancer (NSCLC) is one of the leading causes of death worldwide. In pat…
…safety of immune checkpoint inhibitors (ICIs) for patients with interstitial lung disease and non-small cell lung cancer (ILD-NSCLC) are unclear.Methods …
… a female in her late 70s who underwent lobectomy for suspected non-small cell lung cancer. Pathological assessment revealed adenocarcinoma with backgroun…
…ls correlated with poor immunotherapy response in patients with non-small cell lung cancer.Conclusions Targeted elimination of clonally expanded intratumo…
…kbone for advanced, driver-negative non-small cell lung cancer (NSCLC), delivering meaningful survival gains; yet for most, disease c…